WEKO3
アイテム
{"_buckets": {"deposit": "3cead2f6-0cf4-456f-9626-3dee6e634e86"}, "_deposit": {"created_by": 1, "id": "82904", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "82904"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00082904", "sets": ["29"]}, "author_link": ["952251", "952252", "952253", "952244", "952256", "952246", "952248", "952255", "952247", "952258", "952249", "952257", "952254", "952245", "952250"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2021-04-15", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "[Objective]\n99mTc-GSA scintigraphy is performed for patients before and after carbon-ion radiotherapy (CIRT) for liver tumors in our hospital. It is essential to assess liver reserve capacity and follow-up post-CIRT value for the long term. In this study, we evaluated the usefulness of 99mTc-GSA dynamic scintigraphy for the follow-up assessment of liver reserve capacity in patients before and after CIRT.\n[Materials and Methods]\nEleven patients who received 99mTc-GSA scintigraphy imaging before CIRT, and twice during 3-18 months after CIRT were enrolled in this investigation. After intravenous injection of 99mTc-GSA, dynamic and SPECT imaging were performed using a gamma camera. The maximal GSA removal rate (GSA-Rmax), GSA-Rmax of the predicted residual liver after CIRT (GSA-RL) were calculated by applying 99mTc-GSA dynamics of heart and liver to a five-compartment model. GSA-Rmax was followed before CIRT and twice after CIRT. \n[Results]\nGSA-RL before CIRT and GSA-Rmax of first post-CIRT (3-12 months after CIRT), GSA-Rmax of second post-CIRT (6-18 months after CIRT) were 0.45 ± 0.17, 0.38 ± 0.12, 0.44 ± 0.16 mg/min, respectively (n.s.). The residual liver reserve after first and second post-CIRT may reflect long-term liver reserve.\n[Conclusion] \n99mTc-GSA scintigraphy was useful for the follow-up assessment of liver reserve capacity in patients before and after CIRT for liver tumors.\n", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "第80回日本医学放射線学会総会", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "山崎, 香奈"}], "nameIdentifiers": [{"nameIdentifier": "952244", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "西井, 龍一"}], "nameIdentifiers": [{"nameIdentifier": "952245", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "牧島, 弘和"}], "nameIdentifiers": [{"nameIdentifier": "952246", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "金子, 崇"}], "nameIdentifiers": [{"nameIdentifier": "952247", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "水谷, 陽一"}], "nameIdentifiers": [{"nameIdentifier": "952248", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "田村, 謙太郎"}], "nameIdentifiers": [{"nameIdentifier": "952249", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "東, 達也"}], "nameIdentifiers": [{"nameIdentifier": "952250", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻, 比呂志"}], "nameIdentifiers": [{"nameIdentifier": "952251", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kana, Yamazaki", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "952252", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Ryuichi, Nishii", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "952253", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hirokazu, Makishima", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "952254", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Takashi, Kaneko", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "952255", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Kentaro, Tamura", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "952256", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Tatsuya, Higashi", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "952257", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Hiroshi, Tsuji", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "952258", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "99mTc-GSAシンチグラフィによる肝腫瘍重粒子線治療後患者の肝予備能評価", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "99mTc-GSAシンチグラフィによる肝腫瘍重粒子線治療後患者の肝予備能評価"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/82904", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-06-01"}, "publish_date": "2021-06-01", "publish_status": "0", "recid": "82904", "relation": {}, "relation_version_is_last": true, "title": ["99mTc-GSAシンチグラフィによる肝腫瘍重粒子線治療後患者の肝予備能評価"], "weko_shared_id": -1}
99mTc-GSAシンチグラフィによる肝腫瘍重粒子線治療後患者の肝予備能評価
https://repo.qst.go.jp/records/82904
https://repo.qst.go.jp/records/829042a52f890-ec9e-4e60-8fb2-73bc06590277
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-06-01 | |||||
タイトル | ||||||
タイトル | 99mTc-GSAシンチグラフィによる肝腫瘍重粒子線治療後患者の肝予備能評価 | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
山崎, 香奈
× 山崎, 香奈× 西井, 龍一× 牧島, 弘和× 金子, 崇× 水谷, 陽一× 田村, 謙太郎× 東, 達也× 辻, 比呂志× Kana, Yamazaki× Ryuichi, Nishii× Hirokazu, Makishima× Takashi, Kaneko× Kentaro, Tamura× Tatsuya, Higashi× Hiroshi, Tsuji |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | [Objective] 99mTc-GSA scintigraphy is performed for patients before and after carbon-ion radiotherapy (CIRT) for liver tumors in our hospital. It is essential to assess liver reserve capacity and follow-up post-CIRT value for the long term. In this study, we evaluated the usefulness of 99mTc-GSA dynamic scintigraphy for the follow-up assessment of liver reserve capacity in patients before and after CIRT. [Materials and Methods] Eleven patients who received 99mTc-GSA scintigraphy imaging before CIRT, and twice during 3-18 months after CIRT were enrolled in this investigation. After intravenous injection of 99mTc-GSA, dynamic and SPECT imaging were performed using a gamma camera. The maximal GSA removal rate (GSA-Rmax), GSA-Rmax of the predicted residual liver after CIRT (GSA-RL) were calculated by applying 99mTc-GSA dynamics of heart and liver to a five-compartment model. GSA-Rmax was followed before CIRT and twice after CIRT. [Results] GSA-RL before CIRT and GSA-Rmax of first post-CIRT (3-12 months after CIRT), GSA-Rmax of second post-CIRT (6-18 months after CIRT) were 0.45 ± 0.17, 0.38 ± 0.12, 0.44 ± 0.16 mg/min, respectively (n.s.). The residual liver reserve after first and second post-CIRT may reflect long-term liver reserve. [Conclusion] 99mTc-GSA scintigraphy was useful for the follow-up assessment of liver reserve capacity in patients before and after CIRT for liver tumors. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 第80回日本医学放射線学会総会 | |||||
発表年月日 | ||||||
日付 | 2021-04-15 | |||||
日付タイプ | Issued |